# KMTS (Kestra Medical Technologies, Ltd.) - SEC EDGAR Financial Statements

> Kestra Medical Technologies, Ltd. reported $106.7M in revenue and a net loss of $149.9M for the trailing twelve months ended July 31, 2026 (up 59.9% year over year), with a 53.9% gross margin and a -134.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/KMTS
- Markdown: https://convexityos.com/fundamentals/KMTS.md
- SEC CIK: 0001877184
- Reporting currency: USD
- Latest filing period: July 31, 2026
- Last synced: Nov 20, 2026, 05:24 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001877184&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $106.7M | +59.9% YoY |
| Operating Income | TTM | -$143.5M | -134.5% margin |
| Net Income | TTM | -$149.9M | -140.4% net margin |
| Diluted EPS | TTM | -$2.56 | Split-adjusted |
| Free Cash Flow | TTM | -$122.8M | -115.0% FCF margin |
| Cash & ST Investments | Jul 31, 2026 | $198.9M | Total debt: $76.45M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 |
| --- | --- | --- | --- |
| **Revenue** | $95.13M | $59.81M | $27.81M |
| Cost of Revenue | $46.26M | $35.60M | $27.45M |
| **Gross Profit** | $48.86M | $24.21M | $362K |
| Research & Development | $19.48M | $15.65M | $15.49M |
| Selling, General & Admin | $164.1M | $114.9M | $69.94M |
| Total Operating Expenses | $183.6M | $130.6M | $85.42M |
| **Operating Income** | -$134.7M | -$106.4M | -$85.06M |
| **EBITDA** | -$126.0M | -$98.41M | -$73.50M |
| Interest Income | $8.35M | $3.20M | -- |
| Interest Expense | $7.55M | $7.73M | $6.23M |
| Income Before Tax | -$131.3M | -$113.7M | -$94.10M |
| Income Tax Expense | $294K | $135K | $24K |
| **Net Income** | -$131.6M | -$113.8M | -$94.12M |
| Basic EPS | -$2.43 | -$5.13 | -$5.07 |
| **Diluted EPS** | -$2.43 | -$5.13 | -$5.07 |
| Basic Shares Outstanding | 54.2M | 24.6M | 19.9M |
| Diluted Shares Outstanding | 54.2M | 24.6M | 19.9M |

### Income Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $30.97M | $28.64M | $24.55M | $22.57M | $19.37M | $17.23M | $15.09M | $14.71M |
| Cost of Revenue | $13.47M | $12.96M | $11.65M | $11.14M | $10.52M | $9.60M | $8.54M | $8.88M |
| **Gross Profit** | $17.50M | $15.68M | $12.91M | $11.42M | $8.85M | $7.63M | $6.55M | $5.83M |
| Research & Development | $6.80M | $5.63M | $4.97M | $4.88M | $4.00M | $5.39M | $3.35M | $3.51M |
| Selling, General & Admin | $48.36M | $49.39M | $42.70M | $38.30M | $33.73M | $50.46M | $23.80M | $21.45M |
| Total Operating Expenses | $55.16M | $55.03M | $47.67M | $43.18M | $37.73M | $55.84M | $27.15M | $24.96M |
| **Operating Income** | -$37.66M | -$39.34M | -$34.77M | -$31.75M | -$28.88M | -$48.21M | -$20.60M | -$19.13M |
| **EBITDA** | -$34.99M | -$37.02M | -$32.78M | -$29.38M | -$26.85M | -$46.38M | -$18.71M | -$17.27M |
| Interest Income | $2.12M | $2.23M | $2.16M | $1.80M | $2.17M | $1.66M | $628K | $878K |
| Interest Expense | $1.93M | $1.84M | $1.89M | $1.90M | $1.91M | $1.76M | $1.78M | $2.32M |
| Income Before Tax | -$44.04M | -$38.64M | -$34.13M | -$32.75M | -$25.79M | -$51.01M | -$21.74M | -$20.61M |
| Income Tax Expense | $50K | $192K | $35K | $34K | $33K | $102K | $18K | $8.0K |
| **Net Income** | -$44.09M | -$38.84M | -$34.17M | -$32.78M | -$25.83M | -$52.05M | -$21.51M | -$20.37M |
| Basic EPS | -$0.75 | -- | -$0.61 | -$0.64 | -$0.50 | -- | -$1.25 | -$1.19 |
| **Diluted EPS** | -$0.75 | -- | -$0.61 | -$0.64 | -$0.50 | -- | -$1.25 | -$1.19 |
| Basic Shares Outstanding | 58.6M | -- | 55.8M | 51.4M | 51.3M | -- | 19.9M | 19.9M |
| Diluted Shares Outstanding | 58.6M | -- | 55.8M | 51.4M | 51.3M | -- | 19.9M | 19.9M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $99.71M | $237.6M | $8.25M |
| Short-Term Investments | $96.72M | -- | -- |
| **Cash & Short-Term Investments** | $262.2M | $237.6M | $8.25M |
| Accounts Receivable, Net | $14.54M | $8.08M | $2.00M |
| Other Current Assets | $2.98M | $1.69M | $419K |
| **Total Current Assets** | $222.4M | $255.3M | $14.91M |
| Property, Plant & Equipment, Net | $59.09M | $34.83M | $26.11M |
| Long-Term Investments | $65.77M | -- | -- |
| Other Non-Current Assets | $5.79M | $1.15M | $607K |
| **Total Non-Current Assets** | $136.1M | $40.42M | $31.04M |
| **Total Assets** | $358.5M | $295.7M | $45.95M |
| Accounts Payable | $27.30M | $23.96M | $23.89M |
| **Total Current Liabilities** | $50.37M | $37.98M | $32.97M |
| Long-Term Debt | $42.65M | $41.10M | $42.54M |
| Other Non-Current Liabilities | $306K | $140K | $76K |
| **Total Non-Current Liabilities** | $48.44M | $52.36M | $45.24M |
| **Total Liabilities** | $98.81M | $90.34M | $78.22M |
| **Total Debt (incl. Leases)** | $46.79M | $44.31M | $45.17M |
| Common Stock | $58.38M | $51.35M | $19.91M |
| Retained Earnings | -$651.9M | -$520.2M | -$406.4M |
| Accumulated Other Comp. Income | -$218K | -- | -- |
| Total Equity | $259.7M | $205.4M | -$209.4M |

### Balance Sheet (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Apr 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $68.56M | $99.71M | $291.3M | $175.4M | $201.2M | $237.6M | $8.25M |
| Short-Term Investments | $130.4M | $96.72M | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $244.7M | $262.2M | $291.3M | $175.4M | $201.2M | $237.6M | $8.25M |
| Accounts Receivable, Net | $15.41M | $14.54M | $12.71M | $10.41M | $9.25M | $8.08M | $2.00M |
| Other Current Assets | $2.12M | $2.98M | $1.49M | $1.35M | $1.62M | $1.69M | $419K |
| **Total Current Assets** | $226.3M | $222.4M | $314.1M | $195.4M | $220.7M | $255.3M | $14.91M |
| Property, Plant & Equipment, Net | $63.66M | $59.09M | $53.80M | $45.93M | $40.38M | $34.83M | $26.11M |
| Long-Term Investments | $45.79M | $65.77M | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $6.20M | $5.79M | $5.88M | $1.20M | $1.06M | $1.15M | $607K |
| **Total Non-Current Assets** | $121.1M | $136.1M | $65.28M | $51.29M | $45.60M | $40.42M | $31.04M |
| **Total Assets** | $347.4M | $358.5M | $379.3M | $246.7M | $266.3M | $295.7M | $45.95M |
| Accounts Payable | $25.96M | $27.30M | $24.02M | $20.21M | $18.57M | $23.96M | $23.89M |
| **Total Current Liabilities** | $48.27M | $50.37M | $42.93M | $35.76M | $32.26M | $37.98M | $32.97M |
| Long-Term Debt | $72.50M | $42.65M | $42.26M | $41.87M | $41.49M | $41.10M | $42.54M |
| Other Non-Current Liabilities | $306K | $306K | $140K | $140K | $140K | $140K | $76K |
| **Total Non-Current Liabilities** | $76.73M | $48.44M | $48.42M | $46.86M | $49.88M | $52.36M | $45.24M |
| **Total Liabilities** | $125.0M | $98.81M | $91.35M | $82.62M | $82.14M | $90.34M | $78.22M |
| **Total Debt (incl. Leases)** | $76.45M | $46.79M | $46.55M | $44.80M | $44.59M | $44.31M | $45.17M |
| Common Stock | $59.27M | $58.38M | $58.35M | $51.45M | $51.35M | $51.35M | $19.91M |
| Retained Earnings | -$695.9M | -$651.9M | -$613.0M | -$578.9M | -$546.1M | -$520.2M | -$406.4M |
| Accumulated Other Comp. Income | -$471K | -$218K | -- | -- | -- | -- | -- |
| Total Equity | $222.4M | $259.7M | $288.0M | $164.1M | $184.2M | $205.4M | -$209.4M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 |
| --- | --- | --- | --- |
| Net Income | -$131.6M | -$113.8M | -$94.12M |
| Depreciation & Amortization | $8.71M | $7.97M | $11.56M |
| Stock-Based Compensation | $33.64M | $24.27M | $1.49M |
| Change in Receivables | -$9.06M | -$8.78M | -$2.50M |
| Change in Payables | $4.30M | $2.84M | $7.34M |
| **Operating Cash Flow** | -$81.70M | -$77.61M | -$72.23M |
| Capital Expenditure | -$34.89M | -$22.94M | -$12.23M |
| **Free Cash Flow** | -$116.6M | -$100.5M | -$84.46M |
| Purchases of Investments | -$163.0M | -- | -- |
| **Investing Cash Flow** | -$203.3M | -$23.31M | -$12.23M |
| Common Stock Issued | $149.3M | $215.8M | -- |
| **Financing Cash Flow** | $147.1M | $330.3M | $77.72M |
| **Net Change in Cash** | -$137.9M | $229.3M | -$6.74M |

### Cash Flow Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$44.09M | -$38.84M | -$34.17M | -$32.78M | -$25.83M | -$51.11M | -$21.76M | -$20.62M |
| Depreciation & Amortization | $2.66M | $2.33M | $1.98M | $2.37M | $2.03M | $1.84M | $1.89M | $1.87M |
| Stock-Based Compensation | $9.52M | $10.30M | $10.11M | $8.65M | $4.58M | $22.31M | $459K | $1.12M |
| Change in Receivables | -$48K | -$2.91M | -$2.66M | -$1.71M | -$1.78M | -$963K | -$3.34M | -$1.58M |
| Change in Payables | -$1.88M | $4.95M | $1.73M | $524K | -$2.90M | -$823K | $4.01M | -$2.61M |
| **Operating Cash Flow** | -$32.30M | -$18.72M | -$18.37M | -$18.34M | -$26.27M | -$24.06M | -$18.00M | -$18.06M |
| Capital Expenditure | -$8.34M | -$9.66M | -$9.80M | -$7.26M | -$8.17M | -$7.39M | -$4.06M | -$4.45M |
| **Free Cash Flow** | -$40.63M | -$28.38M | -$28.16M | -$25.61M | -$34.44M | -$31.45M | -$22.06M | -$22.50M |
| Purchases of Investments | -$13.02M | -- | -- | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$21.35M | -$172.7M | -$14.92M | -$7.42M | -$8.23M | -$7.40M | -$4.45M | -$4.42M |
| **Financing Cash Flow** | $22.50M | -$185K | $149.2M | -$27K | -$1.88M | $214.7M | -$119K | -$575K |
| **Net Change in Cash** | -$31.15M | -$191.6M | $115.9M | -$25.79M | -$36.38M | $183.2M | -$22.57M | -$23.05M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 |
| --- | --- | --- | --- |
| **Gross Margin** | 51.4% | 40.5% | 1.3% |
| **Operating Margin** | -141.6% | -177.8% | -305.8% |
| **Net Profit Margin** | -138.4% | -190.3% | -338.4% |
| Return on Assets (ROA) | -36.7% | -38.5% | -204.8% |
| Current Ratio | 4.41x | 6.72x | 0.45x |
| Quick Ratio | 5.49x | 6.47x | 0.31x |
| **Revenue Growth (YoY)** | +59.0% | +115.1% | -- |
| Gross Profit Growth (YoY) | +101.8% | +6587.8% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 53.9% | 51.4% | 48.8% | 46.4% | 43.5% | 40.5% | -- | -- |
| **Operating Margin** | -134.5% | -141.6% | -171.5% | -174.3% | -175.9% | -177.8% | -- | -- |
| **Net Profit Margin** | -140.4% | -138.4% | -173.0% | -178.0% | -180.3% | -190.3% | -- | -- |
| Return on Assets (ROA) | -43.1% | -36.7% | -38.2% | -53.6% | -45.0% | -38.5% | -- | -- |
| Current Ratio | 4.69x | 4.41x | 7.32x | 5.47x | 6.84x | 6.72x | -- | -- |
| Quick Ratio | 5.39x | 5.49x | 7.08x | 5.20x | 6.52x | 6.47x | -- | -- |
| **Revenue Growth (YoY)** | +59.9% | +66.2% | +62.7% | +53.4% | +51.5% | -- | -- | -- |
| Gross Profit Growth (YoY) | +97.7% | +105.5% | +97.1% | +96.0% | +110.7% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
